Form 8-K - Current report:
SEC Accession No. 0001193125-23-179648
Filing Date
2023-06-30
Accepted
2023-06-30 09:17:59
Documents
14
Period of Report
2023-06-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d520803d8k.htm   iXBRL 8-K 26631
2 EX-99.1 d520803dex991.htm EX-99.1 7566
6 GRAPHIC g520803g0630175430211.jpg GRAPHIC 2709
  Complete submission text file 0001193125-23-179648.txt   164016

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20230630.xsd EX-101.SCH 2520
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20230630_lab.xml EX-101.LAB 17939
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20230630_pre.xml EX-101.PRE 11230
8 EXTRACTED XBRL INSTANCE DOCUMENT d520803d8k_htm.xml XML 3504
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 231059772
SIC: 2834 Pharmaceutical Preparations